Icahn Carl C Bausch Health Companies Inc. Transaction History
Icahn Carl C
- $7.37 Billion
- Q4 2024
A detailed history of Icahn Carl C transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Icahn Carl C holds 34,721,118 shares of BHC stock, worth $254 Million. This represents 3.8% of its overall portfolio holdings.
Number of Shares
34,721,118
Previous 34,721,118
-0.0%
Holding current value
$254 Million
Previous $283 Million
1.1%
% of portfolio
3.8%
Previous 2.88%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
270Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Goldentree Asset Management LP New York, NY27.5MShares$201 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$193 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$113 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$95 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$85.4 Million0.0% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.64B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...